Victòria López holds a Biomedical Sciences degree (University of Barcelona-UB, 2019) and a Master of Research in Translational Cancer Medicine (King’s College London-KCL, 2020).

At the end of her Biomedical Sciences degree at University of Barcelona, she went abroad and performed the bachelor’s final thesis in Prof Villadsen’s research group at the Department of Cellular and Molecular Medicine (University of Copenhagen). During this project, she studied the expression of CEACAM5 as well as its tumour-initiating properties in breast cancer. After that, she moved to London and started a 6-months rotation in Dr Aamir Ahmed’s group at the Centre for Stem Cells and Regenerative Medicine (King’s College of London), where she focused on the role of the Wnt/Ca2+ signalling pathway in pancreatic ductal adenocarcinoma. At the end of her Masters, she also collaborated with Prof Mahvash Tavassoli at the Centre for Host Microbiome Interactions (King’s College of London) and wrote a scientific review on tumour hypoxia targeting strategies for head and neck cancer.

In January 2022, she joined the Cancer Epidemiology Research Program (PREC) of the Catalan Institute of Oncology (ICO/IDIBELL) as a PhD student at the Infections and Cancer Laboratory (INCALAB). She is currently taking part in the VIOLIN project, the aim of which is to evaluate the potential of the 9v-HPV vaccine in decreasing HPV viral infectivity and transmission in HPV-positive women.